Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Reexamination Certificate
2006-11-07
2006-11-07
Channavajjala, Lakshmi (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
C424S045000
Reexamination Certificate
active
07132112
ABSTRACT:
A novel method of vehicle modulated administration of an anticonvulsive agent to the mucous membranes of humans and animals is disclosed. The vehicle system is an aqueous pharmaceutical carrier comprising an aliphatic alcohol (10–80%) or a glycol (10–80%), and their combinations with a biological surfactant such as a bile salt or a lecithin. The pharmaceutical composition provides a means to control and promote the rate and extent of transmucosal permeation and absorption of the medicaments via a single and multiple administration. Nasal administration of the pharmaceutical preparation produces a high plasma concentration of the anticonvulsant nearly as fast as intravenous administration. Such compositions are particularly suitable for a prompt and timely medication of patients in the acute and/or emergency treatment of status epilepticus and other fever-induced seizures.
REFERENCES:
patent: 4863720 (1989-09-01), Burghart et al.
patent: 4950664 (1990-08-01), Goldberg
patent: 5428006 (1995-06-01), Bechgaard et al.
patent: 6627211 (2003-09-01), Choi et al.
patent: WO 91/16929 (1991-11-01), None
Supplementary European Search Report, Nov. 29, 2004.
Choi Yong Moon
Kim Kwon H.
Li Lianli
Channavajjala Lakshmi
Gibbons, Del Deo, Dolan Griffinger and Vecchione
SK Corporation
LandOfFree
Transnasal anticonvulsive compositions and modulated process does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Transnasal anticonvulsive compositions and modulated process, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transnasal anticonvulsive compositions and modulated process will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3649647